Life Medical Control (France)
- Research works
- 27 ▼ 46% vs 2013–17
- Citations
- 542 20.0 per fractional work
- Top-10% rate
- 17.0% record average 16.5%
- Open access
- 33% world 28%
Not ranked overall: Life Medical Control (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 51.6×. Every wedge is a field page.
Which keywords describe research at Life Medical Control (France)?
By fractional works in all years, weighted toward what it does more of than the world: Adverse Drug Reactions, Oxidative Stress, Pharmacovigilance, Signal Detection, Epidemiology, Cardiovascular Disease Prevention, Inflammation and Genetic Variants.
- Antiepileptic Drugs
- Cardiovascular Disease Prevention
- Signal Detection
- Inflammation
- Oxidative Stress
- Epidemiology
- Adverse Drug Reactions
- Pharmacovigilance
- Treatment
- Clinical Trials
- Genetic Variants
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 11 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 11 words, with their numbers
- Epidemiology3▲ 2.5×22 topics
- Oxidative Stress2▲ 4.6×9 topics
- Adverse Drug Reactions2▲ 101×2 topics
- Inflammation2▲ 2.7×11 topics
- Pharmacovigilance2▲ 508×1 topic
- Signal Detection2▲ 508×1 topic
- Treatment1▲ 3.8×12 topics
- Cardiovascular Disease Prevention1▲ 54×2 topics
- Clinical Trials1▲ 6.6×4 topics
- Antiepileptic Drugs1▲ 36×2 topics
- Genetic Variants1▲ 17×2 topics
Which research topics does Life Medical Control (France) publish most on?
By volume in 2022–2025: Pharmacovigilance and Adverse Drug Reactions, Lipoproteins and Cardiovascular Health, Pharmacological Effects and Toxicity Studies and Travel-related health issues.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmacovigilance and Adverse Drug Reactions Toxicology 2 works
- 2 Lipoproteins and Cardiovascular Health Surgery 1 works
- 3 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 1 works
- 4 Travel-related health issues Public Health, Environmental and Occupational Health 0 works
- 5 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 0 works
- 6 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
- 7 Epilepsy research and treatment Psychiatry and Mental health 0 works
- 8 Trigeminal Neuralgia and Treatments Pathology and Forensic Medicine 0 works
- 9 Temporomandibular Joint Disorders Complementary and Manual Therapy 0 works
- 10 Maritime Navigation and Safety Ocean Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Life Medical Control (France)'s research output changed?
Output in 2018–2022 was 46% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Toulouse
- Université Toulouse III - Paul Sabatier
- Université Fédérale de Toulouse Midi-Pyrénées
- Université Toulouse - Jean Jaurès
- Institut National Polytechnique de Toulouse
- Université Toulouse-I-Capitole
- Hôpital Rangueil
- Laboratoire d'Analyse et d'Architecture des Systèmes
- Hôpital Purpan
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.